Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Eli Lilly & Co (LLY)  
$905.38 3.66 (0.4%) as of 4:30 Fri 6/28


Download
   
Exchange: New York Stock Exchange
Security Type: Common
Shares Out: 956,580,000
Market Cap: 866.07(B)
Last Volume: 3,374,911 Avg Vol: 3,268,697
52 Week Range: $434.7 - $909.04
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Major

Member Indexes:
    S&P COMPOSITE 1500     NYSE COMPOSITE
    S&P 500

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  720
Guru Rank Value     : 1.4
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Eli Lilly and Company discovers, develops, manufactures, and markets products in a single business segment: human pharmaceutical products. Co.'s products include: diabetes products, oncology products, immunology products, neuroscience products, and other therapies. Co.'s diabetes products include: Baqsimi®, Basaglar®, Humalog®, Humulin®, Jardiance®, Lyumjev®, Trajenta®, and Trulicity®. Co.'s oncology products include: Alimta®, Cyramza®, Erbitux®, Retevmo®, Tyvyt®, and Verzenio®. Co.'s immunology products include: Olumiant® and Taltz®. Co.'s neuroscience products include: Cymbalta®, Emgality®, Reyvow®, and Zyprexa®. Co.'s other therapies include: Bamlanivimab, Cialis®, and Forteo®.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 656
Total Buy Value $0 $0 $0 $199,549
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 1,520,577 2,391,327 3,771,329 6,318,238
Total Sell Value $1,284,658,855 $1,892,909,435 $2,147,483,647 $2,147,483,647
Total People Sold 3 3 4 6
Total Sell Transactions 18 31 50 93
End Date 2024-03-31 2023-12-29 2023-06-30 2022-06-30

   
Records found: 1436
  Page 43 of 58  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Harrington Michael J Senior VP and General Counsel   •       –      –    2017-01-27 4 A $75.38 $1,604,463 D/D 21,285 79,700     -
   Fry Stephen F SVP, HR & Diversity   •       –      –    2017-01-27 4 A $75.38 $1,144,193 D/D 15,179 74,869     -
   Conterno Enrique A Sr. VP & Pres., Lilly Diabetes   •       –      –    2017-01-27 4 A $75.38 $1,523,505 D/D 20,211 133,783     -
   Crowe Maria A President, Mfg. Operations   •       –      –    2017-01-27 4 A $75.38 $1,253,871 D/D 16,634 109,118     -
   Barnes Melissa S Chief Eth/Cmpl Ofcr & SVP, ERM   •       –      –    2017-01-27 4 A $75.38 $461,250 D/D 6,119 14,288     -
   Alvarez Ralph Director   –       •      –    2016-12-30 4/A A $0.00 $0 D/D 158 35,084     -
   Alvarez Ralph Director   –       •      –    2016-12-30 4 A $73.42 $9,912 D/D 135 35,061     -
   Marram Ellen R Director   –       •      –    2016-12-30 4 A $73.42 $6,608 D/D 90 50,215     -
   Lechleiter John C Director   –       •      –    2016-12-16 5 GD $0.00 $0 D/D 375 716,869     -
   Rice Derica W EVP-Global Services and CFO   •       –      –    2016-12-16 5 GD $0.00 $0 I/I 400 365,659     -
   Lilly Endowment Inc 10% Owner   –       –       •   2016-12-16 4 S $72.32 $14,518,477 D/D (200,000) 125,575,804     -
   Zakrowski Donald A Chief Accounting Officer   •       –      –    2016-12-16 4 S $72.13 $72,130 D/D (1,000) 300     -
   Tai Jackson P Director   –       •      –    2016-12-16 4 B $72.64 $99,880 D/D 1,375 48,815 2.39     -
   Mahony Susan SVP & Pres., Lilly Oncology   •       –      –    2016-12-16 4 S $72.68 $83,509 I/I (1,149) 11,479     -
   Mahony Susan SVP & Pres., Lilly Oncology   •       –      –    2016-12-16 4 GD $0.00 $0 D/D 737 67,065     -
   Mahony Susan SVP & Pres., Lilly Oncology   •       –      –    2016-12-16 4 S $72.65 $1,387,106 D/D (19,093) 67,802     -
   Hoover R David Director   –       •      –    2016-12-16 4 B $71.85 $35,925 I/I 500 1,500 2.1     -
   Barnes Melissa S Chief Eth/Cmpl Ofcr & SVP, ERM   •       –      –    2016-12-16 4 S $82.23 $172,107 D/D (2,093) 8,169     -
   Mahony Susan SVP & Pres., Lilly Oncology   •       –      –    2016-12-01 4 D $67.12 $99,942 I/I (1,489) 12,628     -
   Mahony Susan SVP & Pres., Lilly Oncology   •       –      –    2016-12-01 4 OE $0.00 $0 I/I 4,584 14,117     -
   Kaelin William G Jr Director   –       •      –    2016-11-30 4 A $76.64 $160,024 D/D 2,088 11,246     -
   Eskew Michael L Director   –       •      –    2016-11-30 4 A $76.64 $160,024 D/D 2,088 34,017     -
   Baicker Katherine Director   –       •      –    2016-11-30 4 A $76.64 $160,024 D/D 2,088 12,684     -
   Seifert Kathi P Director   –       •      –    2016-11-30 4 A $76.64 $160,024 D/D 2,088 64,716     -
   Tai Jackson P Director   –       •      –    2016-11-30 4 A $76.64 $160,024 D/D 2,088 47,440     -
  1436 Records found
  Previous  40  41  42  43  44  45  46  47  48  49  Next   
  Page 43 of 58
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us